Table 2.
Results of seizures occurring during the LTM.
| Results | Ultra-rapid withdrawal (n = 75) | Rapid withdrawal (n = 35) | p value |
|---|---|---|---|
| Duration of LTM, days | 2.9 ± 0.5 | 3.1 ± 0.8 | 0.14 |
| Latency to the first seizure, h | 19.7 ±18.5 | 30.3 ± 14.7 | 0.008 |
| Number of seizures | 9.35 ± 20.31 | 4.47 ± 3.20 | 0.20 |
| % of patients with ictal onset EEG localization | 45 (60.0%) | 22 (62.9%) | 0.78 |
| Daily seizure frequency | 2.49±6.12 | 1.31±1.25 | 0.26 |
| Daily FBTCS frequency | 0.32±0.66 | 0.29±0.42 | 0.80 |
| No seizures during monitoring | 20 (26.7%) | 5 (14.3%) | 0.15 |
| Seizure type | 0.57 | ||
| FIAS | 43 (57.3%) | 25 (71.4%) | |
| FAS | 12 (16.0%) | 5 (14.3%) | |
| FBTCS | 23 (30.7%) | 14 (40.0%) | 0.34 |
| 4-h SC | 18 (24.0%) | 5 (14.3%) | 0.24 |
| 24-h SC | 31 (41.3%) | 14 (40.0%) | 0.90 |
| SE | 1 (1.3%) | 1 (2.9%) | 0.58 |
| Rescue medication use a | 6 (8.0%) | 5 (14.3%) | 0.31 |
Bold values indicate statistical significance of p < 0.05.
a
Rescue medication use included intravenous diazepam, midazolam, or phenobarbital.
LTM, long-term video-EEG monitoring; FAS, focal-aware seizures; FIAS: focal impaired awareness seizures; FBTCS, focal to bilateral tonic–clonic seizures; SC, seizure clusters; SE, status epilepticus.